CG Shao, NR Sinha, RR Mohan, AD Webel - Biomedicines, 2023 - mdpi.com
Conjunctival fibrosis remains the major impediment to the success of glaucoma filtration surgery. Anti-metabolites remain the gold standard for mitigating post-surgical fibrosis, but …
M Kim, C Lee, R Payne, BYJT Yue, JH Chang… - Survey of …, 2015 - Elsevier
Angiogenesis may pose a clinical challenge in glaucoma, for example, during the wound healing phase after glaucoma filtration surgery and in the severe secondary glaucoma …
V Andrés-Guerrero, L Perucho-González… - Advances in …, 2017 - Springer
The approval of one of the first anti-vascular endothelial growth factor (VEGF) agents for the treatment of neovascular age-related macular degeneration one decade ago marked the …
Background Trabeculectomy is performed as a treatment for glaucoma to lower intraocular pressure (IOP). The surgical procedure involves creating a channel through the wall of the …
T Van Bergen, S Van de Velde… - Clinical …, 2014 - Taylor & Francis
Of all the treatments currently used to lower intraocular pressure in glaucoma patients, filtration surgery is known to be the most effective. However, in a significant percentage of …
M Slabaugh, S Salim - Journal of Ophthalmology, 2017 - Wiley Online Library
A number of antivascular endothelial growth factor agents are currently available to treat various ocular conditions. These agents have similar, but distinct, biologic qualities and …
S Sii, K Barton, LR Pasquale, T Yamamoto… - American Journal of …, 2018 - Elsevier
Purpose To evaluate the standards of harm reporting for glaucoma surgical trials and to develop a classification system for reporting surgical complication severity. Design …